Special Becton Dickinson Fortessa Flow Cytometer

$383,803S10FY2013ODNIH

West Virginia University, Morgantown WV

Investigators

Linked publications, trials & patents

Paper 39244793 Paper 38858423 Paper 38511623 Paper 38390338 Paper 38367056 Paper 38175336 Paper 38099213 Paper 37961596 Paper 37756529 Paper 37545515 Paper 37245409 Paper 37124031 Paper 35927132 Paper 35612302 Paper 35418177 Paper 35288639 Paper 35211125 Paper 35099839 Paper 35080423 Paper 34934004 Paper 34516235 Paper 34496224 Paper 34478449 Paper 34208904 Paper 34169366 Paper 34125597 Paper 33520293 Paper 33455278 Paper 33439777 Paper 33318136 Paper 33199354 Paper 33153066 Paper 33109726 Paper 32843630 Paper 32658184 Paper 32450888 Paper 32030107 Paper 32004683 Paper 31989336 Paper 31778743 Paper 31664743 Paper 31658996 Paper 31602318 Paper 31544167 Paper 31372228 Paper 31010844 Paper 30842470 Paper 30704319 Paper 30559167 Paper 30413212 Paper 30364631 Paper 30211561 Paper 30012638 Paper 29734760 Paper 29733819 Paper 29615492 Paper 29438890 Paper 29399967 Paper 29256569 Paper 29048667 Paper 28974006 Paper 28912540 Paper 28869270 Paper 28722231 Paper 28259974 Paper 28259153 Paper 28235899 Paper 27942214 Paper 27930879 Paper 27920526 Paper 27630827 Paper 27527840 Paper 27358112 Paper 27251061 Paper 27235164 Paper 27084311 Paper 27015556 Paper 26937640 Paper 26891147 Paper 26880992 Paper 26844365 Paper 26820775 Paper 26635625 Paper 26407636 Paper 26332016 Paper 26146559 Paper 26122165 Paper 26079538 Paper 26053033 Paper 25304379 Patent 12214046

Abstract

DESCRIPTION (provided by applicant): The Flow Cytometry Core Facility (FCCF) at the West Virginia University (WVU) School of Medicine is a centralized institutional shared research resource facility that broadly serves the research community at WVU and other regional institutions, and is operated in accordance with contemporary principles in management of institutional shared research facilities. The main priority of the FCCF is to support NIH- funded projects in biomedical research, including research funded with grants from NIGMS/NCRRs Center of Biomedical Research Excellence (CoBRE) and the Idea Network for Biomedical Research Excellence (INBRE) programs. Major instrumentation in the FCCF consists of a 2-laser Becton Dickinson (BD) FACSCalibur analytic flow cytometer, which was purchased with Institutional funds as part of WVUs commitment to biomedical research and has been in operation since 2002, and a 3-laser BD FACSAria cell sorter, which was purchased in 2006 with an NIH Shared Instrumentation Grant. The current proposal describes a plan to replace the FACSCalibur with an LSRFortessa. This upgrade will benefit the research community in 3 tangible ways. It will: 1) enable researchers to shift some of their analytic work from the capable but more expensive FACSAria cell sorter, thereby improving overall efficiency and reducing costs to individual investigators; 2) improve the quality of the data being generated in the FCCF because of the advanced technology provided by the LSRFortessa; and 3) improve availability of analytic services in the FCCF because the FACSCalibur has, over the past 2 years, developed a history of chronic breakdowns despite diligent maintenance and careful oversight by FCCF scientists, as well as exhaustive efforts by Becton Dickinson service technicians.

View original record on NIH RePORTER →